Please provide your email address to receive an email when new articles are posted on . The test met its primary endpoint of concordance with intended use, which was 99%. Patients with a positive ...
The Centers for Medicare & Medicaid Services (CMS) announced Thursday that its Innovation Center is launching a pair of 5-year demonstration projects aimed at evaluating different approaches to shared ...
A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results